Advertisement

Acta Neurologica Belgica

, Volume 119, Issue 1, pp 61–68 | Cite as

Frequency of CD8+ regulatory T cells in the multiple sclerosis patients: a systematic review and meta-analysis

  • Ali Seidkhani-Nahal
  • Ali Noori-ZadehEmail author
  • Salar Bakhtiyari
  • Afra Khosravi
Original Article

Abstract

Multiple sclerosis (MS) is a neuro-immunological demyelinating disease. From the immunological aspects, it is well accepted that T cells play a pivotal role in the etiology of the disease. T helper (Th) 1 and Th17 cells are thought to be the main pathogenic T cells in the pathogenesis of MS and are known as effector T cells. As the self-reactive T lymphocytes can escape clonal deletion in the thymus and subsequently are released into the periphery, there is an urgent need for peripheral tolerance, which is executed by the specialized regulatory T (Treg) cells. Interestingly, CD8+ regulatory T (Treg) cells have also been identified among lymphocyte subtypes. The peripheral CD8+ Treg cells frequency in MS subjects in comparison with healthy controls is the objective of the current study using the systematic review and meta-analysis. A systematic literature search was carried out using specialized biomedical databases of Pubmed, Pubmed Central, Medline, Google Scholar, Embase and SCOPUS databases without the beginning date restriction until January 2018 in English language. The results were as follows: OR 15.548 (95% confidence interval 1.954–123.742) using the random-effects model. The P value for test of significance of the total OR was examined by the z test and calculated as 0.010 (clearly considered as statistically significant). Based on our findings, the number of CD8+ Treg cells in the blood of MS subjects is significantly different as compared to healthy controls.

Keywords

CD8+ regulatory T cells Multiple sclerosis Meta-analysis Odds ratio 

Notes

Acknowledgements

The authors are grateful for the supports of Ilam University of Medical Sciences.

Funding

This study was not funded.

Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Axisa P-P, Hafler DA (2016) Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 29(3):345–353CrossRefGoogle Scholar
  2. 2.
    Galli M, Coghe G, Sanna P, Cocco E, Marrosu MG, Pau M (2015) Relationship between gait initiation and disability in individuals affected by multiple sclerosis. Mult Scler Relat Disord 4(6):594–597CrossRefGoogle Scholar
  3. 3.
    Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Safarnejad Tameshkel F, Keyvani H (2016) 25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: a cross-sectional study. J Neuroimmunol 290:47–48.  https://doi.org/10.1016/j.jneuroim.2015.11.017 CrossRefGoogle Scholar
  4. 4.
    Noori-Zadeh A, Mesbah-Namin SA, Bistoon-Beigloo S et al (2016) Regulatory T cell number in multiple sclerosis patients: a meta-analysis. Mult Scler Relat Disord 5:73–76.  https://doi.org/10.1016/j.msard.2015.11.004 CrossRefGoogle Scholar
  5. 5.
    Piri F, Khosravi A, Moayeri A, Moradipour A, Derakhshan S (2016) The effects of dietary supplements of calcium, vitamin D and estrogen hormone on serum levels of OPG and RANKL cytokines and their relationship with increased bone density in rats. J Clin Diagn Res JCDR 10(9):Af01–Aaf04.  https://doi.org/10.7860/jcdr/2016/18648.8433 Google Scholar
  6. 6.
    Fletcher J, Lalor S, Sweeney C, Tubridy N, Mills K (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1–11CrossRefGoogle Scholar
  7. 7.
    Lovett-Racke AE, Yang Y, Racke MK (2011) Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta (BBA) Mol Basis Dis 1812(2):246–251CrossRefGoogle Scholar
  8. 8.
    Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13(6):829–840CrossRefGoogle Scholar
  9. 9.
    Walker LS, Abbas AK (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2(1):11–19CrossRefGoogle Scholar
  10. 10.
    Bluestone JA, Tang Q (2005) How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 17(6):638–642CrossRefGoogle Scholar
  11. 11.
    Sakaguchi S, Ono M, Setoguchi R et al (2006) Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212(1):8–27CrossRefGoogle Scholar
  12. 12.
    Noori-Zadeh A, Mesbah-Namin SA, Saboor-Yaraghi AA (2017) Epigenetic and gene expression alterations of FOXP3 in the T cells of EAE mouse model of multiple sclerosis. J Neurol Sci 375:203–208.  https://doi.org/10.1016/j.jns.2017.01.060 CrossRefGoogle Scholar
  13. 13.
    Sinha S, Itani FR, Karandikar NJ (2014) Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res 59(1–3):254–265.  https://doi.org/10.1007/s12026-014-8529-9 CrossRefGoogle Scholar
  14. 14.
    Gravano DM, Hoyer KK (2013) Promotion and prevention of autoimmune disease by CD8+ T cells. J Autoimmun 45:68–79.  https://doi.org/10.1016/j.jaut.2013.06.004 CrossRefGoogle Scholar
  15. 15.
    Najafian N, Chitnis T, Salama AD et al (2003) Regulatory functions of CD8+CD28 T cells in an autoimmune disease model. J Clin Investig 112(7):1037–1048CrossRefGoogle Scholar
  16. 16.
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefGoogle Scholar
  17. 17.
    Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846.  https://doi.org/10.1002/ana.20703 CrossRefGoogle Scholar
  18. 18.
    Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302.  https://doi.org/10.1002/ana.22366 CrossRefGoogle Scholar
  19. 19.
    Yang C (2005) Diagnosis of multiple sclerosis. Acta Neurol Taiwan 14(4):213Google Scholar
  20. 20.
    Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M (2017) Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag 13:455–468.  https://doi.org/10.2147/tcrm.s131945 CrossRefGoogle Scholar
  21. 21.
    Kouchaki E, Salehi M, Sharif MR, Nikoueinejad H, Akbari H (2014) Numerical status of CD4+CD25+FoxP3+ and CD8+ CD28-regulatory T cells in multiple sclerosis. Iran J Basic Med Sci 17(4):250Google Scholar
  22. 22.
    Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R (1995) Alterations in levels of CD28/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diagn Lab Immunol 2(2):249–252Google Scholar
  23. 23.
    Frisullo G, Nociti V, Iorio R et al (2010) CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol 71(5):437–441CrossRefGoogle Scholar
  24. 24.
    Pender MP, Csurhes PA, Pfluger CM, Burrows SR (2014) Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis. Mult Scler J 20(14):1825–1832CrossRefGoogle Scholar
  25. 25.
    Correale J, Villa A (2008) Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 195(1):121–134CrossRefGoogle Scholar
  26. 26.
    Correale J, Villa A (2010) Role of CD8+CD25+Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol 67(5):625–638Google Scholar
  27. 27.
    Salehi Z, Doosti R, Beheshti M, Janzamin E, Sahraian MA, Izad M (2016) Differential frequency of CD8+ T cell subsets in multiple sclerosis patients with various clinical patterns. PLoS One 11(7):e0159565CrossRefGoogle Scholar
  28. 28.
    Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefGoogle Scholar
  29. 29.
    Noori-Zadeh A, Mesbah-Namin SA, Bistoon-beigloo S et al (2016) Regulatory T cell number in multiple sclerosis patients: a meta-analysis. Mult Scler Relat Disord 5:73–76CrossRefGoogle Scholar
  30. 30.
    Michel L, Berthelot L, Pettré S et al (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis. J Clin Investig 118(10):3411–3419Google Scholar
  31. 31.
    Huan J, Culbertson N, Spencer L et al (2005) Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81(1):45–52CrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2018

Authors and Affiliations

  1. 1.Department of Clinical Biochemistry, Faculty of MedicineIlam University of Medical SciencesIlamIran
  2. 2.Department of Clinical Biochemistry, Faculty of Allied Medical SciencesIlam University of Medical SciencesIlamIran
  3. 3.Department of Immunology, Faculty of MedicineIlam University of Medical SciencesIlamIran

Personalised recommendations